Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alanyl-Glutamine or Glycine in Hospitalized Children With Persistent Diarrhea or Malnutrition
NCT00133562Phase 3Withdrawn
- Sponsor
- University of Virginia
- Start
- Aug 2004
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in diarrhea and Malnutrition comparing Alanyl-glutamine with Glycine (2 arms). Primary endpoint: Intestinal barrier function measured by lactulose/mannitol test at day 8. Planned start Aug 2004; status: withdrawn.
02
Drugs
alanyl glutamineglycine
03
Conditions
diarrheaMalnutrition
Beyond the preview
Go deeper on NCT00133562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133562.